ARI-1778
/ AbbVie, Arisaph
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2012
Preclinical evaluation of Rev D-4F for the treatment of atherosclerosis
(Abbott)
- Preclinical evaluation of Rev D-4F for the treatment of atherosclerosis
Preclinical • Dyslipidemia
1 to 1
Of
1
Go to page
1